140 related articles for article (PubMed ID: 38192097)
1. Retrospective Analysis of the Impact of High- and Low-Quality Donor Livers for Patients with High-Acuity Illness.
Varghese RK; Handing GE; Montgomery AE; Rana AA; Goss JA
Ann Transplant; 2024 Jan; 29():e941931. PubMed ID: 38192097
[TBL] [Abstract][Full Text] [Related]
2. The Utility of Extended Criteria Donor Livers in High Acuity Liver Transplant Recipients.
Guorgui J; Ito T; Younan S; Agopian VG; Dinorcia J; Farmer DG; Busuttil RW; Kaldas FM
Am Surg; 2021 Dec; 87(10):1684-1689. PubMed ID: 34130521
[TBL] [Abstract][Full Text] [Related]
3. Moderately Macrosteatotic Livers Have Acceptable Long-Term Outcomes but Higher Risk of Immediate Mortality.
Alvikas J; Deeb AP; Jorgensen DR; Minervini MI; Demetris AJ; Lemon K; Chen X; Labiner H; Malik S; Hughes C; Humar A; Tevar A
Transplant Proc; 2021 Jun; 53(5):1682-1689. PubMed ID: 33931249
[TBL] [Abstract][Full Text] [Related]
4. Which recipient pretransplant factors, such as MELD, renal function, sarcopenia, and recent sepsis influence suitability for and outcome after living donor liver transplantation? A systematic review of the literature and expert panel recommendations.
Roll GR; Spiro M; Raptis DA; Jalal A; Yan CT; Olthoff KM; Caicedo JC; Lee KW; Yagi S; Cattral MS; Soin AS;
Clin Transplant; 2022 Oct; 36(10):e14656. PubMed ID: 35340054
[TBL] [Abstract][Full Text] [Related]
5. [The effect of steatotic donor livers on the prognosis of donors and recipients after pediatric living donor liver transplantation].
Yang Y; Dong C; Sun C; Wang K; Zhang W; Zheng WP; Zhang FB; Qin H; Han C; Wang Z; Xu M; Gao W
Zhonghua Wai Ke Za Zhi; 2022 Oct; 60(10):922-929. PubMed ID: 36207981
[No Abstract] [Full Text] [Related]
6. Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score.
Al Sebayel M; Abaalkhail F; Hashim A; Al Bahili H; Alabbad S; Shoukdy M; Elsiesy H
Transplant Proc; 2015 May; 47(4):1211-3. PubMed ID: 26036556
[TBL] [Abstract][Full Text] [Related]
7. Survival benefit of living-donor liver transplantation in patients with a model for end-stage liver disease over 30 in a region with severe organ shortage: a retrospective cohort study.
Yim SH; Kim DG; Kang M; Koh HH; Choi MC; Min EK; Lee JG; Kim MS; Joo DJ
Int J Surg; 2023 Nov; 109(11):3459-3466. PubMed ID: 37565633
[TBL] [Abstract][Full Text] [Related]
8. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
Kwong AJ; Lai JC; Dodge JL; Roberts JP
Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
[TBL] [Abstract][Full Text] [Related]
9. Impact of major hepatocellular carcinoma policy changes on liver transplantation for hepatocellular carcinoma in the United States.
Shah RH; Chyou D; Goldberg DS
Liver Transpl; 2022 Dec; 28(12):1857-1864. PubMed ID: 35585774
[TBL] [Abstract][Full Text] [Related]
10. Survival Outcomes in Liver Transplantation With Elderly Donors: Analysis of Andalusian Transplant Register.
Cepeda-Franco C; Bernal-Bellido C; Barrera-Pulido L; Álamo-Martínez JM; Ruiz-Matas JH; Suárez-Artacho G; Marín-Gómez LM; Tinoco-González J; Díaz-Aunión C; Padillo-Ruiz FJ; Gómez-Bravo MÁ
Transplant Proc; 2016 Nov; 48(9):2983-2986. PubMed ID: 27932125
[TBL] [Abstract][Full Text] [Related]
11. Does Donor Allograft Microsteatosis Matter? Comparison of Outcomes in Liver Transplantation With a Propensity-Matched Cohort.
Croome KP; Lee DD; Croome S; Nakhleh RE; Abader Sedki Senada P; Livingston D; Yataco M; Taner CB
Liver Transpl; 2019 Oct; 25(10):1533-1540. PubMed ID: 31187923
[TBL] [Abstract][Full Text] [Related]
12. Live Donor Liver Transplantation in the United States: Impact of Share 35 on Live Donor Utilization.
Braun HJ; Dodge JL; Grab JD; Schwab ME; Liu IH; Glencer AC; Stock PG; Hirose R; Roberts JP; Ascher NL
Transplantation; 2021 Apr; 105(4):824-831. PubMed ID: 32433235
[TBL] [Abstract][Full Text] [Related]
13. Improved posttransplant mortality after share 35 for liver transplantation.
Kwong AJ; Goel A; Mannalithara A; Kim WR
Hepatology; 2018 Jan; 67(1):273-281. PubMed ID: 28586179
[TBL] [Abstract][Full Text] [Related]
14. Technique and outcome of domino liver transplantation from patients with maple syrup urine disease: Expanding the donor pool for live donor liver transplantation.
Celik N; Kelly B; Soltys K; Squires JE; Vockley J; Shellmer DA; Strauss K; McKiernan P; Ganoza A; Sindhi R; Bond G; Mazariegos G; Khanna A
Clin Transplant; 2019 Nov; 33(11):e13721. PubMed ID: 31556146
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced ultrasonography to evaluate risk factors for short-term and long-term outcomes after liver transplantation: A pilot prospective study.
Zheng BW; Zhang HJ; Gu SJ; Wu T; Wu LL; Lian YF; Tong G; Yi SH; Ren J
Eur J Radiol; 2021 Feb; 135():109475. PubMed ID: 33373895
[TBL] [Abstract][Full Text] [Related]
16. Early graft dysfunction and mortality rate in marginal donor liver transplantation.
Sarkut P; Gülcü B; Işçimen R; Kiyici M; Türker G; Topal NB; Ozen Y; Kaya E
Turk J Med Sci; 2014; 44(4):709-11. PubMed ID: 25551947
[TBL] [Abstract][Full Text] [Related]
17. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
Chok KS; Fung JY; Chan AC; Dai WC; Sharr WW; Cheung TT; Chan SC; Lo CM
Ann Surg; 2017 Jan; 265(1):173-177. PubMed ID: 28009743
[TBL] [Abstract][Full Text] [Related]
18. A comparison of rates and severity of chronic kidney disease in deceased-donor and living-donor liver transplant recipients: times matter.
Yankol Y; Bugeaud E; Zens T; Rizzari M; Mecit N; Leverson GE; Foley D; Mezrich JD; Kanmaz T; Andaçoğlu OM; D'Alessandro AM; Acarlı KS; Kalayoğlu M; Fernandez LA
Turk J Med Sci; 2021 Apr; 51(2):610-622. PubMed ID: 33037873
[TBL] [Abstract][Full Text] [Related]
19. Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients.
Kling CE; Perkins JD; Reyes JD; Montenovo MI
Liver Transpl; 2019 Apr; 25(4):580-587. PubMed ID: 29637730
[TBL] [Abstract][Full Text] [Related]
20. The impact of perceived donor liver quality on post-transplant outcome.
Dirchwolf M; Becchetti C; Stampf S; Haldimann C; Immer F; Beyeler F; Toso C; Dutkowski P; Candinas D; Dufour JF; Banz V;
ANZ J Surg; 2023 Apr; 93(4):918-925. PubMed ID: 36708059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
